lobbying_activities: 1260653

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1260653	bdd45747-b59c-495d-8596-8f713efb7291	Q2	DENNY MILLER ASSOCIATES	25328	CELL THERAPEUTICS	2012	second_quarter	PHA	S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2012-07-11T16:22:16.397000-04:00